Pharma industry must restore payer trust, warns EY
This article was originally published in Scrip
Executive Summary
Restoring and rebuilding trust with those responsible for paying for medicines is probably the most important challenge facing pharma industry bosses. Unfortunately, a survey conducted by Ernst & Young of 60 US and European payers on their current and future needs and preferences and 18 top pharma companies on how well they understand payers' needs and attitudes suggests they have a long way to go.